Advertising and Promotion Regulatory Affairs Conference

Explore the current state of compliance for marketing both biopharmaceuticals and medical devices.

Early Bird Registration Expires

DAYS

HOURS

MINUTES

SECONDS

Back to Agenda

Session 2: Insights from the FDA and Industry on Implementation - Policies, Guidance Documents, Guidelines and Regulations (Part 2)

Division Director

FDA, United States

Director, Office of Prescription Drug Promotion, OMP, CDER

FDA, United States

Session 2: Policies, Guidance, Guidelines and Regulations (Globally) – Insights from the FDA and Industry on Implementation (Part 2)

Have an account?